ATE225647T1 - Dosierungsform zur verabreichung von flüssige arzneimittel formulierung - Google Patents

Dosierungsform zur verabreichung von flüssige arzneimittel formulierung

Info

Publication number
ATE225647T1
ATE225647T1 AT94920203T AT94920203T ATE225647T1 AT E225647 T1 ATE225647 T1 AT E225647T1 AT 94920203 T AT94920203 T AT 94920203T AT 94920203 T AT94920203 T AT 94920203T AT E225647 T1 ATE225647 T1 AT E225647T1
Authority
AT
Austria
Prior art keywords
dosage form
administration
medicinal formulation
liquid medicinal
liquid
Prior art date
Application number
AT94920203T
Other languages
English (en)
Inventor
Steven D Larsen
George V Guittard
Patrick S-L Wong
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE225647T1 publication Critical patent/ATE225647T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT94920203T 1994-06-13 1994-06-13 Dosierungsform zur verabreichung von flüssige arzneimittel formulierung ATE225647T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/006723 WO1995034285A1 (en) 1994-06-13 1994-06-13 Dosage form for administering drug in liquid formulation

Publications (1)

Publication Number Publication Date
ATE225647T1 true ATE225647T1 (de) 2002-10-15

Family

ID=22242671

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94920203T ATE225647T1 (de) 1994-06-13 1994-06-13 Dosierungsform zur verabreichung von flüssige arzneimittel formulierung

Country Status (11)

Country Link
EP (1) EP0768867B1 (de)
JP (1) JP3901727B2 (de)
KR (1) KR100360636B1 (de)
AT (1) ATE225647T1 (de)
AU (1) AU682703B2 (de)
CA (1) CA2185119C (de)
DE (1) DE69431533T2 (de)
DK (1) DK0768867T3 (de)
ES (1) ES2183841T3 (de)
PT (1) PT768867E (de)
WO (1) WO1995034285A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
US6673768B1 (en) 1997-10-16 2004-01-06 Board Of Regents, The University Of Texas System Transgenic animal models for cardiac hypertrophy and methods of use thereof (treating)
KR100620292B1 (ko) * 1998-09-09 2006-09-13 알자 코포레이션 액체 제형물을 포함하는 제형
EP1140012B1 (de) * 1998-12-17 2004-03-03 Alza Corporation Umwandlung von flüssigkeitsgefüllten gelatinkapseln in systeme mit gesteuerter wirkstoffabgabe durch mehrfache beschichtungen
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
UY28056A1 (es) * 2002-10-31 2003-12-31 Alza Corp Formas de dosificacion que proporcionan la liberacion ascendente de una formulacion liquida.
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
AU2004314693B2 (en) 2003-09-26 2011-04-07 Alza Corporation Drug coating providing high drug loading and methods for providing the same
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
MX2008014870A (es) 2006-05-30 2009-02-12 Intarcia Therapeutics Inc Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas.
EP2363112B8 (de) 2006-08-09 2018-11-21 Intarcia Therapeutics, Inc. Osmotisches Verabreichungssystem mit KOLBENANORDNUNG
EP2157967B1 (de) 2007-04-23 2013-01-16 Intarcia Therapeutics, Inc Suspensionsformulierungen insulinotroper peptide und ihre verwendung
CA2691531C (en) 2007-06-22 2016-11-01 Board Of Regents,The University Of Texas System Formation of stable submicron peptide or protein particles by thin film freezing
US8343140B2 (en) 2008-02-13 2013-01-01 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
CA2743789C (en) 2008-11-16 2017-10-31 Board Of Regents, The Univesity Of Texas System Low viscosity highly concentrated suspensions
AU2010298733B2 (en) 2009-09-28 2014-10-09 Intarcia Therapeutics, Inc. Rapid establishment and/or termination of substantial steady-state drug delivery
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
TWI615155B (zh) * 2011-11-01 2018-02-21 拜耳股份有限公司 滲透活性的陰道遞送系統
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
EP3302354B1 (de) 2015-06-03 2023-10-04 i2o Therapeutics, Inc. Systeme zum einsetzen eines implantats
RU2760007C2 (ru) 2016-05-16 2021-11-22 Интарсия Терапьютикс, Инк. Полипептиды, селективные к рецепторам глюкагона, и способы их применения
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
IL307966A (en) 2017-01-03 2023-12-01 Intarcia Therapeutics Inc Methods involving continuous administration of a GLP-1 receptor agonist and co-administration of a drug
DK3735228T3 (da) 2018-03-05 2022-03-14 Amneal Complex Products Res Llc Programmerbar farmaceutiske sammensætninger til krono-lægemiddelfrigivelse
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
US11547670B2 (en) 2019-03-05 2023-01-10 Amneal Complex Products Research Llc Delayed release methylphenidate compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814180A (en) * 1984-03-21 1989-03-21 Alza Corporation Agent dispenser comprising a semipermeable wall surrounding single-piece or two-piece container
GB2155889B (en) * 1984-03-21 1988-03-02 Alza Corp Dispenser-capsule
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug

Also Published As

Publication number Publication date
CA2185119C (en) 2005-07-26
WO1995034285A1 (en) 1995-12-21
EP0768867B1 (de) 2002-10-09
JP3901727B2 (ja) 2007-04-04
KR100360636B1 (ko) 2002-12-18
DE69431533T2 (de) 2003-10-02
KR970703752A (ko) 1997-08-09
PT768867E (pt) 2003-01-31
EP0768867A1 (de) 1997-04-23
JPH10501261A (ja) 1998-02-03
AU7108094A (en) 1996-01-05
DK0768867T3 (da) 2002-10-28
ES2183841T3 (es) 2003-04-01
CA2185119A1 (en) 1995-12-21
AU682703B2 (en) 1997-10-16
DE69431533D1 (de) 2002-11-14

Similar Documents

Publication Publication Date Title
DE69431533D1 (de) Dosierungsform zur verabreichung von flüssige arzneimittel formulierung
ATE116543T1 (de) Osmotisches dosiersystem zur verabreichung von flüssigen arzneimitteln.
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
ATE96308T1 (de) Dosierform fuer verabreichung in der humanmedizin.
MX171191B (es) Composiciones farmaceuticas de glipizida
DE69225135D1 (de) Dosierungsform zur verzoegerten wirkstofffreisetzung
ATE204467T1 (de) Orale darreichungsform
ES2089011T3 (es) Excipiente lipidico de administracion nasal y aplicacion topica.
FI955124A0 (fi) Protonipumppuinhibiittorin sisältävä eläinlääkeseos
ES2060593T3 (es) Sistema de aporte de farmacos.
NO874960L (no) Flytende doseringsform for oral administrasjon av et farmasoeytisk aktivt stoff.
ATE79619T1 (de) Arzneimittel.
ATE427103T1 (de) Orale verabreichung von adenosin analogen
ES2165997T3 (es) Uso de una formulacion farmaceutica pediatrica que comprende amoxicilina y clavulanato.
ATE292453T1 (de) Antivirale arznei
MY101784A (en) Novel pharmacological compounds
ES2160821T3 (es) Uso de una composicion que comprende amoxicilina y acido clavulanico para la produccion de un medicamento para el tratamiento de infecciones bacterianas en pacientes pediatricos.
GB9212450D0 (en) New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them
BR9610983A (pt) Formas estáveis de administração farmacêuticas contendo paratormônio
PT705204E (pt) Saquetas para medicamentos liquidos
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
ATE173923T1 (de) Oralanzuwendende flüssige arzneizubereitung enthaltend 2-(4-isobutylphenyl)propionsäure
AU625402B2 (en) Transdermal system exhibiting graduated drug release and its use for the local or systemic administration of active substances
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
PT627916E (pt) Composicao farmaceutica utilizavel como analgesico contendo o acido (r)-2-(3-benzoilfenil)propionico

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee